8-K filed October 10, 2023, 7:59 PM ET ticker PCRX CIK 0001396814

leadership confidence high sentiment neutral materiality 0.50

Pacira BioSciences appoints four new independent directors, expanding board to 12

Pacira BioSciences, Inc.

Board increased from 10 to 12 directors; appointed Alethia Young (Audit), Marcelo Bigal (Science & Tech), Abraham Ceesay (Compensation), Michael Yang (Compensation).
All four are independent under Nasdaq standards; bring scientific, commercial, and financial expertise.
Appointments effective immediately; each receives standard non-employee director compensation.
Appointments enhance racial and gender diversity on the board.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Abraham Ceesay

Director

PCRX · Pacira BioSciences, Inc.

Effective: 2023-10-06
Filed: October 10, 2023, 7:59 PM ET

appointed each of Alethia Young, Marcelo Bigal, Abraham Ceesay and Michael Yang as a member of the Board

Appointed

Michael Yang

Director

PCRX · Pacira BioSciences, Inc.

Effective: 2023-10-06
Filed: October 10, 2023, 7:59 PM ET

appointed each of Alethia Young, Marcelo Bigal, Abraham Ceesay and Michael Yang as a member of the Board

Appointed

Alethia Young

Director

PCRX · Pacira BioSciences, Inc.

Effective: 2023-10-06
Filed: October 10, 2023, 7:59 PM ET

appointed each of Alethia Young, Marcelo Bigal, Abraham Ceesay and Michael Yang as a member of the Board

Appointed

Marcelo Bigal

Director

PCRX · Pacira BioSciences, Inc.

Effective: 2023-10-06
Filed: October 10, 2023, 7:59 PM ET

appointed each of Alethia Young, Marcelo Bigal, Abraham Ceesay and Michael Yang as a member of the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Abraham Ceesay was appointed as Director at Pacira BioSciences, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed each of Alethia Young, Marcelo Bigal, Abraham Ceesay and Michael Yang as a member of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Yang was appointed as Director at Pacira BioSciences, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed each of Alethia Young, Marcelo Bigal, Abraham Ceesay and Michael Yang as a member of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Alethia Young was appointed as Director at Pacira BioSciences, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed each of Alethia Young, Marcelo Bigal, Abraham Ceesay and Michael Yang as a member of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Marcelo Bigal was appointed as Director at Pacira BioSciences, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed each of Alethia Young, Marcelo Bigal, Abraham Ceesay and Michael Yang as a member of the Board

View on SEC.gov

Pacira BioSciences, Inc. filing history →

Source: SEC EDGAR

accession 0001396814-23-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.